
Elevated liver function tests in COVID-19
Author(s) -
Ricketta Clark,
Bradford Waters,
Ansley Grimes Stanfill
Publication year - 2021
Publication title -
the nurse practitioner/the nurse practitioner
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.15
H-Index - 21
eISSN - 1538-8662
pISSN - 0361-1817
DOI - 10.1097/01.npr.0000722316.63824.f9
Subject(s) - covid-19 , liver injury , liver function tests , liver function , liver damage , liver dysfunction , medicine , transaminase , alanine transaminase , multiorgan failure , gastroenterology , pathology , biology , enzyme , biochemistry , disease , outbreak , infectious disease (medical specialty)
COVID-19 causes severe respiratory and multiorgan failure, including liver damage and elevated transaminase levels. This article addresses the potential causes of liver function abnormalities in patients diagnosed with COVID-19 and management approaches for NPs focusing on preventing and alleviating liver injury.